Corporate overview
| Company name | Bonac Corporation |
|---|---|
| Co-founder and Chairman | Tadaaki Ohgi, Ph.D. |
| President and CEO | Hirotake Hayashi |
| Director |
Kihito Takahashi, M.D., Ph.D., MBA Kyoko Miyoshi, M.Sc. Masahiko Kuroda, M.D., Ph.D. (Tokyo Medical University, Department of Molecular Pathology Professor & Chairman, Part-time) Takeo Kitayama (SUMITOMO CHEMICAL Co., Ltd., Associate Officer, External Director) Philippe Fauchet, OBE (External Director) Yoshihiko Okamoto (Koei Chemical Co., Ltd., Advisor, External Director) Yoshihiko Matsuo (Audit and Supervisory Committee Member, External Director) Yoshiro Hori (Audit and Supervisory Committee Member, External Director) Tokuichiro Ide (Audit and Supervisory Committee Member, External Director) |
| Executive officer | Nobuhiro Noro, Ph.D. |
| Date of establishment | February 2010 |
| Capital | 3,877million yen （As of the end of December, 2017） |
| Business | RNA therapeutics Patent license Technology consulting |
| Head Office |
Fukuoka Bio Factory, 1488-4 Aikawa, Kurume Fukuoka 839-0861, JAPAN TEL: 81-942-32-6700 FAX: 81-942-32-4611 |
| Fukuoka Branch |
Shin-KBC Building 8th Floor 1-1-35 Nagahama, Chuou-ku, Fukuoka, 810-0072, JAPAN TEL: 81-92-713-8801 FAX: 81-92-713-8802 |
| Tokyo Branch |
The fifth Ujiie Building ♯502, 2-16-8,Uchikanda,Chiyoda-ku,Tokyo 101-0047,JAPAN TEL: 81-3-6206-8604 FAX: 81-3-6206-8704 |
